Diabetic Retinopathy - Market Insights, Epidemiology and Market Forecast - 2023

  • ID: 4300600
  • Drug Pipelines
  • 88 pages
  • DelveInsight
1 of 3
Diabetic Retinopathy - Market Insights, Epidemiology and Market Forecast-2023 report provides an overview of the epidemiology trends of Diabetic Retinopathy in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Diabetic Retinopathy prevalent or incident cases segmented by age, sex and subpopulations. The report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Diabetic Retinopathy. The report provides a comprehensive review of the market trends, drivers, barriers, key company profiles including its business and product developments The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by a team of industry experts.

Key Coverage and Benefits:
  • The report will help in developing business strategies by understanding the trends shaping and driving the global Diabetic Retinopathy market.
  • Identifying prevalent patient populations as well as risk factors in the global Diabetic retinopathy market will help to improve product design, pricing, and launch plans.
  • Organize marketing efforts by identifying the best opportunities for Diabetic retinopathy therapeutics in each of the markets covered.
  • To understand the future market competition in the global Diabetic Retinopathy market and Insightful review of the key market drivers and barriers.
  • To understand the regulatory scenario in major markets.
  • The report also covers the detailed global historical and forecasted Diabetic Retinopathy market covering United States, European Union 5 (EU5 - Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.
Note: Please allow up to 24 hours for delivery after payment has been made.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
Report Introduction
Diabetic Retinopathy (DR) Market Overview at a Glance
Global Market Size of DR in 2015
Global Market Size of DR in 2023
Diabetic Retinopathy: Overview
Stages
Symptoms
Types
Pathophysiology
Etiology
Risk Factors
Disease Burden
Unmet Needs
Epidemiology of Diabetic Retinopathy in 7MM (2013-2023)
United States
Sex Specific Prevalence of Diabetes Retinopathy in US
Age - Specific Prevalence of Diabetes Retinopathy in US
Sub-type Prevalence of Diabetes Retinopathy in US
EU5
United Kingdom
Sex Specific Prevalence of Diabetes Retinopathy in UK
Age - Specific Prevalence of Diabetes Retinopathy in UK
Sub-type Prevalence of Diabetes Retinopathy in UK
France
Sex Specific Prevalence of Diabetes Retinopathy in France
Age - Specific Prevalence of Diabetes Retinopathy in France
Sub-type Prevalence of Diabetes Retinopathy in France
Italy
Sex Specific Prevalence of Diabetes Retinopathy in Italy
Age - Specific Prevalence of Diabetes Retinopathy in Italy
Sub-type Prevalence of Diabetes Retinopathy in Italy
Germany
Sex Specific Prevalence of Diabetes Retinopathy in Germany
Age - Specific Prevalence of Diabetes Retinopathy in Germany
Sub-type Prevalence of Diabetes Retinopathy in Germany
Spain
Sex Specific Prevalence of Diabetes Retinopathy in Spain
Age - Specific Prevalence of Diabetes Retinopathy in Spain
Sub-type Prevalence of Diabetes Retinopathy in Spain
Japan
Sex Specific Prevalence of Diabetes Retinopathy in Japan
Age - Specific Prevalence of Diabetes Retinopathy in Japan
Sub-type Prevalence of Diabetes Retinopathy in Japan
Treatment Algorithm
Marketed Drugs
EYLEA
Description
Regulatory Milestones
Advantages and Disadvantages
Product Profile
Safety & Efficacy
Side effects of Eylea
Lucentis
Description
Regulatory Milestones
Advantages and Disadvantages
Product Profile
Safety & Efficacy
Side effects of Lucentis
Global Diabetic Retinopathy: Country-Wise Market Analysis
Total Market Size of Diabetic Retinopathy (2013-2023)
United States
EU5
United Kingdom
Germany
France
Italy
Spain
Japan
Market Drivers
Market Barriers
Appendix
Report Methodology
Consulting Services
Disclaimer
About

List of Tables
Table 1: Prevalent Population of Diabetic Retinopathy in United States (2013-2023)
Table 2: Sex Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
Table 3: Age-Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
Table 4: Sub-type Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
Table 5: Prevalent Population of Diabetic Retinopathy in United Kingdom (2013-2023)
Table 6: Sex Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
Table 7: Age-Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
Table 8: Sub-type Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
Table 9: Prevalent Population of Diabetic Retinopathy in France (2013-2023)
Table 10: Sex Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
Table 11: Age-Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
Table 12: Sub-type Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
Table 13: Prevalent Population of Diabetic Retinopathy in Italy (2013-2023)
Table 14: Sex Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
Table 15: Age-Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
Table 16: Sub-type Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
Table 17: Prevalent Population of Diabetic Retinopathy in Germany (2013-2023)
Table 18: Sex Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
Table 19: Age-Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
Table 20: Sub-type Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
Table 21: Prevalent Population of Diabetic Retinopathy in Spain (2013-2023)
Table 22: Sex Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
Table 23: Age-Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
Table 24: Sub-type Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
Table 25: Prevalent Population of Diabetic Retinopathy in Japan (2013-2023)
Table 26: Sex Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)
Table 27: Age-Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)
Table 28: Sub-type Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)
Table 29: Total Market size of Diabetic Retinopathy in USD Billion (2013-2023)
Table 30: United States Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
Table 31: United Kingdom Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
Table 32: Germany Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
Table 33: France Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
Table 34: Italy Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
Table 35: Spain Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
Table 36: Japan Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)

List of Figures
Figure 1: Risk Factors of Diabetic Retinopathy
Figure 2: Prevalent Population of Diabetic Retinopathy in United States (2013-2023)
Figure 3: Sex Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
Figure 4: Age-Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
Figure 5: Sub-type Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
Figure 6: Prevalent Population of Diabetes Retinopathy in United Kingdom (2013-2023)
Figure 7: Sex Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
Figure 8: Age - Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
Figure 9: Sub-type Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
Figure 10: Prevalent Population of Diabetic Retinopathy in France (2013-2023)
Figure 11: Sex Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
Figure 12: Age - Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
Figure 13: Sub-type Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
Figure 14: Prevalent Population of Diabetic Retinopathy in Italy (2013-2023)
Figure 15: Sex Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
Figure 16: Age-Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
Figure 17: Sub-type Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
Figure 18: Prevalent Population of Diabetic Retinopathy in Germany (2013-2023)
Figure 19: Sex Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
Figure 20: Age - Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
Figure 21: Sub-type Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
Figure 22: Prevalent Population of Diabetic Retinopathy Spain (2013-2023)
Figure 23: Sex Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
Figure 24: Age - Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
Figure 25: Sub-type Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
Figure 26: Prevalent Population of Diabetic Retinopathy in Japan (2013-2023)
Figure 27: Sex Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)
Figure 28: Age-Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)
Figure 29: Sub-type Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)
Figure 30: Total Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
Figure 31: United States Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
Figure 32: United Kingdom Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
Figure 33: Germany Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
Figure 34: France Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
Figure 35: Italy Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
Figure 36: Spain Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
Figure 37: Japan Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll